Report ID: SQMIG35D2230
Heart Transplant Market Size, Share, Growth Analysis, By Type of Transplant(Orthotopic Heart Transplant, Heterotopic Heart Transplant, and Pediatric Heart Transplant), By Donor Type (Deceased Donor Heart Transplant, and Living Donor Heart Transplant), By Indication(Ischemic Cardiomyopathy, Dilated Cardiomyopathy, Congenital Heart Disease, Valvular Heart Disease), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2230 |
Region:
Global |
Published Date: March, 2024
Pages:
223
|
Tables:
91 |
Figures:
76
Heart Transplant Market Competitive Landscape
The competitive surroundings of the Heart Transplant marketplace is characterised by a mix of hooked up clinical establishments, main pharmaceutical corporations, and corporations that specialize in organ transplantation. Prominent players in the marketplace encompass renowned scientific facilities with widespread experience in cardiac surgical procedures and transplant processes, contributing to their management on this specialised field. Pharmaceutical groups play a essential function, presenting immunosuppressive medications integral to publish-transplant care. Additionally, collaborations and partnerships between medical institutions and pharmaceutical firms similarly shape the aggressive dynamics.
Top Player’s Company Profiles
- Abbott Laboratories
- Novartis AG
- Pfizer Inc.
- Johnson & Johnson
- Astellas Pharma Inc.
- Bristol Myers Squibb Company
- Sanofi S.A.
- Fresenius SE & Co. KGaA
- Medtronic plc
- Merck & Co., Inc.
- Roche Holdings AG
- AstraZeneca plc
- Gilead Sciences, Inc.
- Novo Nordisk A/S
- Baxter International Inc.
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Thermo Fisher Scientific Inc.
- Terumo Corporation
- Siemens Healthineers AG
Heart Transplant Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
